6.595
Schlusskurs vom Vortag:
$6.62
Offen:
$6.59
24-Stunden-Volumen:
4,065
Relative Volume:
0.05
Marktkapitalisierung:
$98.59M
Einnahmen:
$41.94M
Nettoeinkommen (Verlust:
$-7.40M
KGV:
-13.36
EPS:
-0.4935
Netto-Cashflow:
$1.29M
1W Leistung:
-0.31%
1M Leistung:
-16.67%
6M Leistung:
+90.62%
1J Leistung:
+91.18%
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
Firmenname
Cumberland Pharmaceuticals Inc
Sektor
Telefon
615-255-0068
Adresse
1600 WEST END AVENUE, NASHVILLE,, TN
Compare CPIX vs TAK, TEVA, HLN, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
CPIX
Cumberland Pharmaceuticals Inc
|
6.58 | 99.19M | 41.94M | -7.40M | 1.29M | -0.4935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.30 | 58.50B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.82 | 42.84B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
HLN
Haleon Plc Adr
|
9.145 | 40.68B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
ZTS
Zoetis Inc
|
73.45 | 30.40B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
496.53 | 21.36B | 3.17B | 1.29B | 1.01B | 27.09 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2012-11-12 | Bestätigt | UBS | Neutral |
| 2011-02-01 | Bestätigt | UBS | Neutral |
| 2010-12-16 | Herabstufung | UBS | Buy → Neutral |
| 2010-08-17 | Herabstufung | Jefferies | Buy → Hold |
| 2010-08-17 | Bestätigt | Morgan Joseph | Buy |
| 2010-08-17 | Bestätigt | UBS | Buy |
| 2010-05-14 | Bestätigt | Morgan Joseph | Buy |
Alle ansehen
Cumberland Pharmaceuticals Inc Aktie (CPIX) Neueste Nachrichten
CUMBERLAND PHARMACEUTICALS ANNOUNCES SPECIAL DIVIDEND OF $1.50 PER SHARE - Eastern Progress
Cumberland Pharmaceuticals (CPIX) Slips 0.75% as Shares Test Support Near $6.31Passive Flow - dars.gov.et
Cumberland Pharmaceuticals (NASDAQ:CPIX) Shares Cross Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Cumberland Pharmaceuticals (CPIX) Slips 2.2% to $8.46, Testing Key Support at $8.04Unusual Put Volume - vinanet.vn
Cumberland Pharmaceuticals (NASDAQ:CPIX) Shares Pass Above Two Hundred Day Moving AverageHere's Why - MarketBeat
Enterprise value to revenue forward of Cumberland Pharmaceuticals Inc. – NASDAQ:CPIX - TradingView
Price to sales forward of Cumberland Pharmaceuticals Inc. – NASDAQ:CPIX - TradingView
Price to book forward of Cumberland Pharmaceuticals Inc. – NASDAQ:CPIX - TradingView
Cumberland Pharmaceuticals (CPIX) Slips 1.4% to $7.79 as Shares Remain RangeboundHigh Conviction Picks - dars.gov.et
Cumberland Pharmaceuticals Stock Price Forecast. Should You Buy CPIX? - StockInvest.us
Cumberland Pharmaceuticals Inc (CPIX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cumberland Pharmaceuticals: Pivot Into Drug Development Creates Risk, Opportunity (CPIX) - Seeking Alpha
Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Cumberland Pharmaceuticals (CPIX) Edges Higher: Stock Gains 1.56% to $7.80 as Resistance at $8.19 Comes into FocusLong Term Entry Picks - dars.gov.et
Cumberland Pharmaceuticals (CPIX) Slips 1.04% as Shares Test Key Support Near $7.22Turnaround Stocks - vinanet.vn
Cumberland Pharmaceuticals (CPIX) Stock Cools As Cash Rich Biotech Pivot Begins - Sahm
Cumberland Pharmaceuticals Inc (CPIX) (Q2 2026) Earnings Call Highlights: Strategic ... - Yahoo Finance
Earnings call transcript: Cumberland Pharmaceuticals swings on Q2 2026 reset - Investing.com
Cumberland Pharmaceuticals Q2 Earnings Call Highlights - MarketBeat
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction - TradingView
Cumberland Pharmaceuticals (NASDAQ:CPIX) Issues Quarterly Earnings Results - MarketBeat
Cumberland Pharmaceuticals posts $4.1 million Q2 loss after Apotex deal - Quiver Quantitative
Cumberland: Q2 Earnings Snapshot - GreenevilleSun.com
Cumberland Pays $1.50 Dividend After Apotex Brand Sale - Stock Titan
Cumberland Pharmaceuticals Reports Company Up - Moomoo
ETFs Investing in Cumberland Pharmaceuticals Inc. Stocks - TradingView
Cumberland Pharmaceuticals To Go Ex-Dividend On August 3rd, 2026 With 1.5 USD Special Dividend Per Share - Moomoo
Possible Generic Drug Tariffs and 2 Microcaps - TradingView
Cumberland's ifetroban is in Phase 2 studies for four diseases - Stock Titan
Cumberland Pharmaceuticals Inc (CPIX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CPIX|Cumberland Pharmaceuticals Inc|Price:7.030|Chg%:+0.420 - TradingKey
Cumberland Pharmaceuticals Inc. Revenue Breakdown – NASDAQ:CPIX - TradingView
TradingKey - TradingKey
Cumberland Pharmaceuticals Inc (CPIX) Institutional Confidence - TradingKey
Cumberland Pharmaceuticals Inc (CPIX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cumberland Pharmaceuticals Inc (CPIX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cumberland Pharmaceuticals Inc - TradingKey
Cumberland Pharmaceuticals (CPIX) Slides 5.4%: Support Levels Under ScrutinyInitial Balance - dars.gov.et
CPIX|Cumberland Pharmaceuticals Inc|Price:6.610|Chg%:-0.375 - TradingKey
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Passes Above 200 Day Moving AverageHere's What Happened - MarketBeat
Cumberland Pharmaceuticals | 8-K: Current report - Moomoo
Cumberland Pharmaceuticals declares $1.50 dividend - MSN
Cumberland Pharmaceuticals Inc. (CPIX) Gains Momentum, Approaches Key Resistance LevelDealer Positioning - vinanet.vn
Cumberland Pharma Board of Directors Has Authorized and Declared a Special Cash Div of $1.50 a Shr >CPIX - Moomoo
ELTP vs. CPIX: Which Pharma Stock Is the Better Buy Right Now? - The Globe and Mail
BRIEF-Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share - Dailyhunt
Cumberland Pharmaceuticals 8-K Filing July 2026: Key Company Details, Stock Info, and Address on NASDAQ CPIX - Minichart
Cumberland Pharmaceuticals Announces Special Dividend, Share Buyback - TipRanks
Cumberland Pharmaceuticals declares $1.50 special dividend, $5M buyback after $100M Apotex deal - TradingView
Cumberland Pharmaceuticals (Nasdaq: CPIX) returns cash after $100M Apotex deal - Stock Titan
Cumberland Pharmaceuticals Inc. (CPIX) Stock: Unveils Special Dividend While Advancing Ifetroban Rare Disease Pipeline - parameter.io
Finanzdaten der Cumberland Pharmaceuticals Inc-Aktie (CPIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):